ArticleMaterials today. Bio2026
X-optogenetic inhibition of VTA GABA neurons for wireless deep-brain stimulation and suppression of scratching behavior in freely moving mice.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
X-ray-mediated wireless optogenetic neurostimulation (X-optogenetics) at any brain depth is a powerful technology for neuroscience studies and neurological disorder treatment. However, there is still a lack of effective and safe X-optogenetic neural inhibition technology because of the need for a precise spectral match degree between scintillator and inhibitory opsins and sufficient light intensity emitted from X-ray-induced scintillation. Here, we report an efficient X-optogenetic neural inhibition technology that achieves both wireless deep-brain stimulation and rapid behavioral suppression in freely moving mice. First, we developed two novel inorganic scintillators: terbium-doped gadolinium oxysulfide (Gd
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.